The recovery of self tolerance in SLE

Grabar P . Autoantibodies and the physiological role of immunoglobulins . Immunol Today 1983; 4: 337–340 .

Galili U , Flechner I , Knyszinski A et al. The natural anti-α-galactosyl. IgG on human normal senescent red blood cells . Br J Haematol 1986; 62: 317–324 .

Cabral AR , Cabiedes J , Alarcón-Segovia D . Hemolytic anemia related to an IgM autoantibody to phosphatidylcholine that binds in vitro to stored and to bromelain-treated human erythrocytes . J Autoimmun 1990; 3: 773–787 .

Cabiedes J , Cabral AR , Alarcón-Segovia D . Hidden anti-phospholipid antibodies in normal human sera circulate as immune complexes whose antigen can be removed by heat, acid, hypermolar buffers or phospholipase treatments . Eur J Immunol 1998, 28: 2108–2114 .

Alarcón-Segovia D and Alarcón-Riquelme ME . Etiopathogenesis of systemic lupus erythematosus: a tale of three troikas. In: Lahita RG (ed). Systemic Lupus Erythematosus. Academic Press: San Diego, CA , 1999, pp 55–65.

Alarcón-Segovia D . The future of treatment for systemic lupus erythematosus . Israel Med Assoc J 2001; 3: 127–130 .

Harrison LC , Halfter DA . Antigen-specific therapy for autoimmune disease . Curr Opin Immunol 2000; 12: 704–711 .

Malvey EN , Telander DG , Vanesek TL , Mueller DL . The role of clonal anergy in the avoidance of autoimmunity: inactivation of autocrine growth without loss of effector function . Immunol Rev 1998; 165: 301–318 .

Lentz VM , Manser T . Self-limiting systemic autoimmune disease during reconstruction of T cell-deficient mice with synergic cells: support for a multifaceted role of T cells in the maintenance of peripheral B cell tolerance . Int Immunol 2000; 12: 1483–1497 .

Ofosu-Appiah W , Sfeir G , Viti D , Burashnikova E . Suppression of systemic lupus erythematosus disease in mice by oral administration of kidney extract . J Autoimmun 1999; 13: 405–414 .

Hahn BH , Singh RR , Wong WK , Tsao BP et al. Treatment with a consensus peptide based on amino acid sequences in autoantibodies prevents T cell activation by autoantigens and delays disease onset in murine lupus . Arthrit Rheum 2001; 44: 432–441 .

Jones DS , Borstad PA , Field MJ et al. Immunospecific reduction of antioligonucleotide conjugate (LJP394), a therapeutic candidate for the treatment of lupus nephritis . J Med Chem 1995; 38: 3138–3144 .

Weisman MH , Bluestein HG , Berner CM , de Haan HA . Reduction of circulating dsDNA antibody titer after administration of LJP394 . J Rheumatol 1997; 24: 314–318 .

Alarcón-Segovia D , Tumlin J , Furie R et al. SLE trial shows fewer renal flares in LJP 394-treated patients with high-affinity antibodies to LJP 394: trial results . Arthrit Rheum 2000; 43: S272-S272 (abstract).

McNeeley PA , Iverson GM , Furie RA et al. Pre-treatment affinity for LJP 394 influences pharmacodynamic response in lupus patients . Lupus 2001; 10: 526–532 .

Alarcón-Segovia D , Fishbein E , Alcalá et al. The range and specificity of antinuclear antibodies in systemic lupus erythematosus Clin Exp Immunol 1970; 6: 557–571 .

Wang Y , Mi J , Cao X . Anti-DNA antibodies exhibit different binding motif preferences for single stranded or double stranded DNA . Immunol Lett 2000; 73: 29–34 .

Aguilera I , Melero AJ , Núñez-Roldán A , Sánchez B . Molecular structure of eight human autoreactive monoclonal antibodies . Immunology 2001; 102: 273–280 .